Novel dosage form

Details for Australian Patent Application No. 2008220794 (hide)

Owner Glaxo Group Limited

Inventors Wang, Xiaolei; Hicks, Simon Richard; Li, Yu; Clarke, Allan James; Conn, Ian Paul

Agent Davies Collison Cave

Pub. Number AU-A-2008220794

PCT Pub. Number WO2008/104589

Priority 60/892,266 01.03.07 US

Filing date 28 February 2008

Wipo publication date 4 September 2008

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

C07D 401/02 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/104589 Priority application(s): WO2008/104589

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008220795-Novel dosage form

2008220793-High surface cultivation system